Fri, February 14, 2025

by: WOPRAI

As of Feb 14th, 2025, there has been substantial selling of Blockchain Loyalty Corp. in recent trading

by: WOPRAI

As of Feb 14th, 2025, there has been substantial selling of in recent trading

by: WOPRAI

As of Feb 14th, 2025, there has been substantial selling of RF Acquisition Corp. in recent trading

by: WOPRAI

52 Earnings Releases for Feb 14th, 2025

by: MSN

Warren Buffett: Saving and Investing Tips for Retirees

Warren Buffett is one of the most famous and popular investors of all time. The billionaire CEO of Berkshire Hathaway is as well-known for his homespun with as his long-term investment success,

by: Investing

Baidu to make next-gen Ernie AI model open-source amid DeepSeek shakeup

The move marks a reversal in Baidu's stance on open-sourcing its AI models, as CEO Robin Li repeatedly advocated closed-source AI models as the only viable means of AI development.
Thu, February 13, 2025

by: MSN

The Best Stocks to Invest $25,000 in Right Now

Got a bunch of cash to deploy? These four Canadian stocks would make an excellent start for a long-term investment portfolio. The post The Best Stocks to Invest $25,000 in Right Now appeared first on The Motley Fool Canada.

by: MSN

Why did the AMP share price just crash more than 13%?

AMP shares are taking a beating on Friday. But why? The post Why did the AMP share price just crash more than 13%? appeared first on The Motley Fool Australia.

by: MSN

You thought Magnificent 7 and tech stocks were the only winners of AI boom? Wait! Here's a sector whose stocks could be an under-the-radar winner, say analysts

Retail stores such as Walmart and Target stand to gain from the enormous artificial intelligence investments being made by technology giants, without having to spend billions on infrastructure. According to Morgan Stanley analysts,

by: Kiplinger

Stock Market Today: Stocks Pop on Time-Delayed Tariffs

Reddit ( RDDT) stock fell 5.2% after the social media platform topped fourth-quarter revenue and earnings expectations but came up short on user numbers.

by: MSN

Jim Cramer Says Jefferies Financial Group Inc. (JEF) 'Had A Surprisingly Bad Quarter'

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at where Jefferies Financial Group Inc. (NYSE:JEF) stands against the other stocks.

by: MSN

What Is a Bond? A Beginner's Guide to How Bonds Work

What is a bond? They're fixed-rate assets investors buy to balance portfolio risk. Keep reading to learn about the important details of investing in bonds.

by: MSN

The $85 billion ASX 200 gold stock trading at a 35% discount

The ASX 200 gold stock mines some 6 million ounces of gold every year. The post The $85 billion ASX 200 gold stock trading at a 35% discount appeared first on The Motley Fool Australia.

by: MSN

I would follow Warren Buffett's advice and buy high-quality ASX shares at fair prices

Follow these steps and you could invest like the Oracle of Omaha. The post I would follow Warren Buffett's advice and buy high-quality ASX shares at fair prices appeared first on The Motley Fool Australia.

by: MSN

10 Best Solar Stocks To Invest In Today

For patient investors, the promise of solar may one day produce sizable investment returns. Learn about the best solar stocks to consider for your portfolio.

by: Kiplinger

The Trade Desk Stock Plunges on Soft Revenue, Weak Outlook

The Trade Desk stock is plunging Thursday after the advertising platform missed fourth-quarter revenue expectations and issued weak first-quarter guidance.

by: MSN

Corcept Therapeutics stock soars to all-time high of $71.3

Corcept Therapeutics Incorporated (NASDAQ:CORT) has reached an unprecedented milestone as its stock price soared to an all-time high of $71.3. According to InvestingPro data, the company maintains a "GREAT" financial health score and has achieved impressive revenue growth of ~40% over the last twelve months.

by: MSN

Jim Cramer Says He's 'Worried' About The Wendy's Company (WEN)

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at where The Wendy's Company (NASDAQ:WEN) stands against the other stocks. Jim Cramer,

by: MSN

Jim Cramer on TETRA Technologies, Inc. (TTI): 'It's A Very Good Company. It Did Come Up From The Ashes'

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at where TETRA Technologies, Inc. (NYSE:TTI) stands against the other stocks.

by: MSN

Jim Cramer on Abbott Laboratories (ABT): 'Big Position For The Trust'

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. Jim Cramer,

by: MSN

Jim Cramer on The Hershey Company (HSY): 'Wake Me Up When It Sells At 14 Times Earnings And Then I Might Even Consider It'

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at where The Hershey Company (NYSE:HSY) stands against the other stocks. Jim Cramer,

by: MSN

Brokers Suggest Investing in Blue Bird (BLBD): Read This Before Placing a Bet

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

by: MSN

JPM highlights potential tariff impact on Brazil, India stocks

JPMorgan released a report today discussing the potential effects of reciprocal tariffs on global markets, particularly focusing on Brazil and India. The firm noted that while China has been the subject of broad-based tariffs from the United States,

by: WOPRAI

Short squeeze is starting in shares of IVDN at $0.3, after crossing above the $0.277 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of EVER at $21.35, after crossing above the $21.348 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of EEFT at $107.775, after crossing above the $107.389 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of DPG at $11.89, after crossing above the $11.819 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CROX at $105.606, after crossing above the $97.922 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of AVNT at $43.14, after crossing above the $41.989 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ATLCY at $15.42, after crossing above the $15.352 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ANCTF at $51.08, after crossing above the $50.826 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ADYEY at $18.65, after crossing above the $17.373 Trigger Price

by: MSN

Jim Cramer on Nu Holdings Ltd. (NU): 'It's Very Expensive'

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at where Nu Holdings Ltd. (NYSE:NU) stands against the other stocks. Jim Cramer,

by: Kiplinger

Reddit Stock Falls After User Number Disappoints

Reddit stock is down Thursday after the social media platform fell short of expectations on a key metric for its fourth quarter. Here's what you need to know.

by: Kiplinger

Why Robinhood Stock Is Soaring After Earnings

Robinhood stock is sizzling Thursday after the online trading platform reported impressive fourth-quarter results. Here's what investors need to know.

by: WOPRAI

Short squeeze is starting in shares of STGW at $6.585, after crossing above the $6.398 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of PDFS at $27.74, after crossing above the $27.661 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of MDV at $15.43, after crossing above the $15.291 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TNA at $43.14, after crossing above the $42.993 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CZR at $37.7, after crossing above the $37.114 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CUBE at $42.08, after crossing above the $42.064 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CEVA at $36.515, after crossing above the $34.925 Trigger Price

by: MSN

Kraft Heinz cut by BofA and Citi as outlook disappoints

Kraft Heinz was downgraded by both Bank of America and Citi following its disappointing FY25 sales and earnings outlook, with analysts citing persistent revenue challenges and a lack of meaningful investment to drive future growth.

by: MSN

Jim Cramer on Rockwell Automation, Inc. (ROK): 'I Have Been Disappointed In How Much They're Really Doing In Robotics'

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at where Rockwell Automation, Inc. (NYSE:ROK) stands against the other stocks.

by: Investing

FTSE 100 Live: Shares in Barclays, BAT and Unilever tumble under bond pressure

"Wide discounts, underperformance and, in some cases, board inaction have provoked the ire of activist investor Saba Capital Management, which earlier this week launched a new campaign to persuade four trusts to convert to open-ended funds," says this article on Trustnet.

by: WOPRAI

Short squeeze is starting in shares of WSTG at $127.23, after crossing above the $25.23 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of WISH at $7.915, after crossing above the $5.596 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of VVI at $41.36, after crossing above the $30.193 Trigger Price

Corcept Therapeutics stock soars to all-time high of $71.3

Corcept Therapeutics Incorporated (NASDAQ:CORT) has reached an unprecedented milestone as its stock price soared to an all-time high of $71.3. According to InvestingPro data, the company maintains a "GREAT" financial health score and has achieved impressive revenue growth of ~40% over the last twelve months.

Corcept Therapeutics Inc.'s stock surged to an all-time high of $71.30, driven by positive developments in its clinical trials and market expansion. The company, known for its focus on treatments for severe metabolic, oncologic, and psychiatric disorders, announced promising results from its ongoing studies, particularly for its lead drug, Korlym, used in treating Cushing's syndrome. Additionally, Corcept has been expanding its research into new indications for Korlym and other pipeline drugs, which has bolstered investor confidence. The stock's rise reflects not only the company's strong performance but also the growing market interest in specialized pharmaceuticals addressing unmet medical needs.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/top-stocks/corcept-therapeutics-stock-soars-to-all-time-high-of-71-3/ar-AA1yZsEt